ScoreWhy is Guangdong Biolight Meditech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.03% and Operating profit at -175.48% over the last 5 years
2
Flat results in Jun 25
- INTEREST(9M) At CNY 19.29 MM has Grown at 14.67%
- OPERATING CASH FLOW(Y) Lowest at CNY 31.38 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 3.49%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 20.35%, its profits have risen by 56.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Guangdong Biolight Meditech Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Guangdong Biolight Meditech Co., Ltd.
7.1%
0.86
49.07%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.03%
EBIT Growth (5y)
-175.48%
EBIT to Interest (avg)
4.56
Debt to EBITDA (avg)
0.43
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.57
Tax Ratio
2.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.43%
ROE (avg)
8.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.42
EV to EBIT
-22.00
EV to EBITDA
-1007.55
EV to Capital Employed
1.39
EV to Sales
1.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.33%
ROE (Latest)
-4.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET PROFIT(HY)
Higher at CNY 1.25 MM
NET SALES(Q)
Highest at CNY 273.84 MM
-8What is not working for the Company
INTEREST(9M)
At CNY 19.29 MM has Grown at 14.67%
OPERATING CASH FLOW(Y)
Lowest at CNY 31.38 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.49%
RAW MATERIAL COST(Y)
Grown by 15.55% (YoY
Here's what is working for Guangdong Biolight Meditech Co., Ltd.
Net Profit
At CNY 1.25 MM has Grown at 149.7%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Profit
Higher at CNY 1.25 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Net Sales
Highest at CNY 273.84 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Here's what is not working for Guangdong Biolight Meditech Co., Ltd.
Interest
At CNY 19.29 MM has Grown at 14.67%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 3.49% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Cash Flow
Lowest at CNY 31.38 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Raw Material Cost
Grown by 15.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
